Viewing Study NCT00458250

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:53 PM
Ignite Modification Date: 2026-01-24 @ 7:14 AM
Study NCT ID: NCT00458250
Status: COMPLETED
Last Update Posted: 2008-11-18
First Post: 2007-04-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H
Sponsor: Tehran University of Medical Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myeloid, Acute View
None Leukemia, Lymphoblastic, Acute View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hematopoietic Stem Cell Transplantation View
None Haploidentical View
None Hematologic Neoplasms View
None human, Bone Marrow View
None Granulocyte Colony-stimulating Factor View
None CAMPATH View
None Alemtuzumab View
None AML View
None ALL View
None 10. Eligibility View